Transindia Real Estate Ltd.

BSE

Price on BSE 26 Feb,14:55 LIVE

24.22

+0.72

(+3.06%)

Volume :
473.00

Prev Close :
23.50

Day's H/L (Rs.) :
24.22 - 23.25

52wk H/L (Rs.) :
41.30 - 22.40

Mkt Cap (Rs. Cr) :
595.09

NSE

Price on NSE 26 Feb,15:13 LIVE

24.09

+0.49

(+2.08%)

Volume :
114,619.00

Prev Close :
23.60

Day's H/L (Rs.) :
24.40 - 23.27

52wk H/L (Rs.) :
37.95 - 22.33

Mkt Cap (Rs. Cr) :
0.00

Report Card - Transindia Real Estate Ltd.

PE Ratios

16.06

EPS (Rs.)

1.46

Sales (Rs. Cr)

11.50

Face Value (Rs.)

Net Profit Margin(%)

65.56

Last Bonus

Last Dividend(%)

Return on Average Equity

2.82

News for Transindia Real Estate Ltd.

Allcargo Logistics Restructuring Approved by NCLT

Allcargo Logistics gets NCLT approval for restructuring. Demerges international supply chain into Allcargo Global. Details inside.

Oct 13, 2025 16:40

Allcargo Group Appoints Ravi Jakhar as Director - Strategy & CFO

Allcargo Group has appointed Ravi Jakhar as Director for strategy and group CFO. Jakhar previously served as Group Chief Strategy Officer and will oversee finance and strategy across the group's...

May 15, 2025 16:45

Ram Walase Appointed CEO of Transindia Real Estate

Transindia Real Estate Ltd appoints Ram Walase as its new CEO, bringing 25 years of leadership experience in real estate, infrastructure, project finance, and consulting.

Apr 29, 2024 12:40

Transindia Sells Haryana Logistics Park for Rs 636.71 cr

Transindia Real Estate has sold its logistics park in Jhajjar, Haryana for Rs 636.71 crore. The company will use the proceeds to expand its operations and invest in emerging opportunities.

Feb 29, 2024 18:03

Allcargo Logistics & Gati Approve Business Restructuring

Allcargo Logistics and Allcargo Gati boards approve restructuring of businesses, including demerger of ISC business into Allcargo ECU Ltd. The scheme aims to create operational synergies and direct...

Dec 21, 2023 22:36

More News for Transindia Real Estate Ltd. »

News for Miscellaneous

Alembic Pharma Gets USFDA Nod for Generic Drug

Alembic Pharma receives USFDA approval for generic Lamotrigine tablets, used to treat seizures. ANDA equivalent to GlaxoSmithKline's Lamictal.

Feb 26, 2026 14:51

Acerpure Eyes Emerging Markets After India Success

Acerpure plans to expand to Philippines, Vietnam, Thailand, and Indonesia after success in India. Focus on local manufacturing and investment.

Feb 26, 2026 14:49

Gushwork AI Raises Rs 81 Cr Funding

Gushwork AI secures Rs 81 cr funding led by Susquehanna Asia VC. Plans to invest in AI product development, talent & customer acquisition.

Feb 26, 2026 14:48

India Trade Policy Review at WTO in July 2026

India's 8th Trade Policy Review at WTO will take place in July 2026. Focus on digital customs reforms and TFA implementation.

Feb 26, 2026 14:33

Swiggy & IRCTC: Food on Train Expands to 152 Stations

Swiggy and IRCTC expand 'Food on Train' service to 152 stations across India. Holi special menu & train-friendly dishes launched.

Feb 26, 2026 14:25

More News »

Top News

Alembic Pharma Gets USFDA Nod for Generic Drug

Alembic Pharma receives USFDA approval for generic Lamotrigine tablets, used to treat seizures. ANDA equivalent to GlaxoSmithKline's Lamictal.

Feb 26, 2026 14:51

Acerpure Eyes Emerging Markets After India Success

Acerpure plans to expand to Philippines, Vietnam, Thailand, and Indonesia after success in India. Focus on local manufacturing and investment.

Feb 26, 2026 14:49

Gushwork AI Raises Rs 81 Cr Funding

Gushwork AI secures Rs 81 cr funding led by Susquehanna Asia VC. Plans to invest in AI product development, talent & customer acquisition.

Feb 26, 2026 14:48

Cytiva Expands Bengaluru Fast Trak Facility

Cytiva expands its Fast Trak process development facility in Bengaluru to support biopharma companies in India and Asia-Pacific.

Feb 26, 2026 14:48

India Trade Policy Review at WTO in July 2026

India's 8th Trade Policy Review at WTO will take place in July 2026. Focus on digital customs reforms and TFA implementation.

Feb 26, 2026 14:33

More Top News »

Sectoral Indices Market Indicators Listed Companies Gainers Losers Mutual Funds Portfolio Watchlist